Skip to content

Released Oct 29, 2024, after the close

10-Q filed Oct 30, 2024, 30 days after period end · 0001653477-24-000100

Q3 2024 · 10-Q
Revenue$333.80M−25.2% vs Q3 2023−14.5% vs Q2 2024
Net Income-$107.20MN/M vs Q3 2023N/M vs Q2 2024
EPS Diluted-$2.94N/M vs Q3 2023N/M vs Q2 2024
Gross Profit$131,600,000+2.0%
Operating Income$110,200,000−0.2%
Operating Cash Flowderived$46,500,000−55.8%
Free Cash Flowderived$28,500,000−60.3%
Margins · derived
Gross margin39.4%+10.5 pt vs Q3 2023
Operating margin33.0%+8.3 pt vs Q3 2023
Net margin-32.1%−37.8 pt vs Q3 2023

What the release said

The release

Same quarter

MetricQ3 2024Q3 2023Q3 2022Q3 2021
Revenue$333.80M$446.00M$482.00M$376.80M
Net Income-$107.20M$25.20M$75.40M-$4.20M
EPS Diluted-$2.94$0.69$1.98-$0.11

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR